Grant Award Details

Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy
Grant Number: 
DISC2P-11946
Project Objective: 
  • The objective is to validate a stem cell-based microphysiological system (MPS) for predicting cardiac toxicity, including modeling drug-drug interactions in polytherapy for the treatment of SARS-CoV-2 in patients with diverse backgrounds
Investigator: 
Type: 
PI
Disease Focus: 
COVID-19
Infectious Disease
Human Stem Cell Use: 
iPS Cell
Award Value: 
$224,500
Status: 
Active

Grant Application Details

Application Title: 
  • Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy
Public Abstract: 
Statement of Benefit to California: